Skip to main content

Market Overview

Chevron, Fiserv And A Health Care Stock On CNBC's 'Final Trades'

Share:
Chevron, Fiserv And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management named Chevron Corporation (NYSE:CVX) his final trade.

On Feb. 12, Chevron announced plans to slash its workforce by up to 20% and intends to commence major layoffs this year, aiming to complete the majority by the end of 2026. The move is part of a broader cost-cutting plan, with the company targeting a reduction of $2 billion to $3 billion by the end of 2026, reported CNBC

Jason Snipe of Odyssey Capital Advisors said he likes Fiserv, Inc. (NYSE:FI). On March 19, Fiserv announced that it had acquired CCV, a payment solutions provider in the Netherlands, Belgium and Germany, to drive growth in the European market.

Don't forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners picked UnitedHealth Group Incorporated (NYSE:UNH) as his final trade.

On Thursday, UnitedHealth Group's Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturer pricing actions. The company plans a full implementation by January 2028.

Price Action:

  • Chevron shares gained 0.4% to close at $164.77 on Thursday.
  • Fiserv rose 0.7% to settle at $221.79 during Thursday's session.
  • UnitedHealth Group shares gained 1.6% to close at $511.30 on Thursday.

Check This Out:

Photo: Courtesy: zignal_88 on Shutterstock.com

 

Related Articles (CVX + FI)

View Comments and Join the Discussion!

Posted-In: CNBC Halftime Report Final Trades Jason Snipe Jim LebenthalNews Markets Media Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com